Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
How it helps disc herniation specifically: Upregulates tendon-related growth factors BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus Promotes angiogenesis increases VEGF expression, improving blood supply to the avascular disc environment Neuroprotective effects multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury Systemic anti-inflammatory suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids Protocol: Dose: 250500mcg/day subcutaneous injection Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues) Duration: 68 weeks loading phase, reassess at week 8 Most people notice reduced nerve pain and improved mobility within 24 weeks
Retatrutide hit a larger figure in a shorter trial
Deficient synthesis of glutathione underlies oxidative stress in aging
Dosing can be subcutaneous (most common) or intramuscular, localized near the injury or systemic (abdominal)
Bresciani, E., Bussi, A., Bazzigaluppi, E., and Balestrieri, G
Pharmacokinetic Differences From Semaglutide Both liraglutide and semaglutide work through the same GLP-1 receptor, but their pharmacokinetic profiles differ substantially
US$ 28.56
US$ 23.58
US$ 27.73
US$ 23.87
